Adithya Balasubramanian

Aug 7, 2023 | pathsocjournals.onlinelibrary.wiley.com | Adithya Balasubramanian |Thomas John |David Adams

INVITED COMMENTARY †Invited commentary for Hill W, Lim EL, Weeden CE et al. Lung adenocarcinoma promotion by air pollutants. Nature 2023; 616: 159–167. Conflict of interest statement: TJ reports fees from advisory boards for: Roche, Merck, MSD, Puma, AstraZeneca, BMS, Novartis, Amgen, Gilead, PharmaMar, and Specialised Therapeutics which are outside the submitted work. DJA is supported by AstraZeneca, OpenTargets, and is a paid consultant for Microbiotica.